“Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases -2/-9 via ROS/ERK1/2 pathways”, Bangladesh J Pharmacol, vol. 9, no. 3, pp. 419–427, Sep. 2014, doi: 10.3329/bjp.v9i3.19730.